<?xml version="1.0" encoding="UTF-8"?>
<p>Four parameters of public health importance were estimated by our MCMC framework: the date of introduction, the human infectious period, the human (intrinsic) incubation period, and the case observation rate (
 <xref rid="table4" ref-type="table">Table 4</xref>). The posterior for the introduction date showed a strong support for an introduction into FSA in early-mid December 2014 (estimated median: 
 <inline-formula>
  <math id="inf49">
   <msup>
    <mn>10</mn>
    <mrow>
     <mi>t</mi>
     <mo>⁢</mo>
     <mi>h</mi>
    </mrow>
   </msup>
  </math>
 </inline-formula> of December), i.e. around 7–8 weeks before the first notified case (
 <xref ref-type="fig" rid="fig3">Figure 3A</xref>). The estimated human infectious period was 
 <inline-formula>
  <math id="inf50">
   <mrow>
    <mi/>
    <mo>≈</mo>
    <mn>6</mn>
   </mrow>
  </math>
 </inline-formula> days (
 <xref ref-type="fig" rid="fig3">Figure 3C</xref>, median = 5.9, 95% CI [5.47–6.14]), which was very similar to the estimated incubation period (
 <xref ref-type="fig" rid="fig3">Figure 3D</xref>, median = 5.8, 95% CI [5.6–6.15]) and in line with previously estimated ranges for ZIKV (
 <xref rid="table3" ref-type="table">Table 3</xref>). In this context it is important to note that informative priors had been used for these 2 parameters (
 <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2.</xref>), and the posterior for the incubation period presented an adjustment of 
 <inline-formula>
  <math id="inf51">
   <mrow>
    <mi/>
    <mo>≈</mo>
    <mrow>
     <mo>-</mo>
     <mn>0.5</mn>
    </mrow>
   </mrow>
  </math>
 </inline-formula> days relative to the proposed distribution from the literature.
</p>
